H
Hongchang International Co Ltd
OTC:HCIL
Hongchang International Co Ltd
OTC:HCIL
Price:
0.1144
USD
Market Cap:
$59.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Hongchang International Co Ltd
OTC:HCIL
|
CN |
|
T
|
Thai Steel Cable PCL
SET:TSC
|
TH |
|
D
|
Dragonfly Energy Holdings Corp
NASDAQ:DFLI
|
US |
|
BioXcel Therapeutics Inc
NASDAQ:BTAI
|
US |
|
S
|
Sinar Eka Selaras PT
IDX:ERAL
|
ID |
|
Iberdrola SA
OTC:IBDRY
|
ES |
|
exactEarth Ltd
TSX:XCT
|
CA |
|
Shree Cement Ltd
NSE:SHREECEM
|
IN |
|
United Spirits Ltd
NSE:MCDOWELL-N
|
IN |
|
Heidrick & Struggles International Inc
NASDAQ:HSII
|
US |
|
A
|
Axis Real Estate Investment Trust
KLSE:AXREIT
|
MY |
|
H
|
Himalaya Shipping Ltd
OSE:HSHIP
|
BM |
|
Sezzle Inc
ASX:SZL
|
US |
|
S
|
Shenzhen Weiguang Biological Products Co Ltd
SZSE:002880
|
CN |
|
A
|
Absolute Clean Energy PCL
SET:ACE
|
TH |
Relative Value
The Relative Value of one HCIL stock under the Base Case scenario is hidden USD. Compared to the current market price of 0.1144 USD, Hongchang International Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HCIL Relative Value
HIDDEN
Multiples Across Competitors
HCIL Competitors Multiples
Hongchang International Co Ltd Competitors
Hongchang International Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
H
|
Hongchang International Co Ltd
OTC:HCIL
|
59.4m USD | 5.2 | 59.2 | 42.6 | 62.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.1B USD | 4.1 | 28 | 16.1 | 22.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
169.7B USD | 17 | 60 | 45.5 | 56 | |
| US |
|
Stryker Corp
NYSE:SYK
|
128.4B USD | 5.1 | 39.5 | 20.2 | 24.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.6B USD | 3.2 | 24.3 | 13.4 | 19.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103B USD | 5.1 | 35.6 | 20.9 | 28.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.9B USD | 8 | 45 | 24.8 | 27.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.2B EUR | 1.8 | 19.8 | 11.1 | 15.7 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46B USD | 10.8 | 44 | 31.2 | 34.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
43.9B USD | 2 | 25.5 | 10.1 | 17 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32.9B USD | 6.2 | 22.6 | 15.9 | 17.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
